Vertex Solutions, a small business known for the manufacturing of systems integration and advanced training technologies, has ...

In a report released today, Chris Quintero from Morgan Stanley maintained a Buy rating on Vertex (VERX – Research Report), with a price target ...

Representative Jefferson Shreve recently dipped into Vertex Pharmaceuticals stock, buying between $15,001 and $50,000 worth on March 13th. He revealed this transaction in a disclosure dated April 11th ...

Gemini 2.5 Flash isn't available just yet, but it's coming soon to Vertex AI, AI Studio, and the standalone Gemini app. On a ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

A pivotal trial of Zimislecel, a fully differentiated islet cell therapy with standard immunosuppression, is on track to complete enrollment and dosing in the first half of this year. Vertex ...

Zimislecel (formerly VX-880), Vertex’s investigational fully differentiated islet cell therapy with standard immunosuppression, is in the Phase 3 portion of the Phase 1/2/3 study in patients ...

A container ship which collided with a US tanker in the North Sea, leading to its captain being charged with gross negligence manslaughter, has arrived in Aberdeen. Portuguese vessel Solong was ...

Keep updated, follow The Business Standard's Google news channel The report documents religious freedom conditions in 2024 and recommends policies to the White House, Congress and State Department to ...

Nkarta is laying off a third of its workforce, and more than half its executive team, in a bid to survive long enough to see if an experimental cell therapy it’s developing will show promise against ...